These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4382351)

  • 1. [The role of attention in occupational therapy and psychopharmacotherapy with neuroleptic drugs with special consideration of Parkinson's syndrome].
    Bösch L
    Nervenarzt; 1967 Apr; 38(4):158-66. PubMed ID: 4382351
    [No Abstract]   [Full Text] [Related]  

  • 2. Case studies in the advancement of Parkinson's disease.
    Frei K; Truong DD; Wolters E
    CNS Spectr; 2008 Dec; 13(12 Suppl 18):1-6. PubMed ID: 19179948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Extrapyramidal symptoms during the use of neuroleptics].
    Ditfurth HV
    Nervenarzt; 1967 Apr; 38(4):151-5. PubMed ID: 4382350
    [No Abstract]   [Full Text] [Related]  

  • 4. Improvement in Parkinson's disease patients achieved by coordination dynamics therapy.
    Schalow G; Pääsuke M; Ereline J; Gapeyeva H
    Electromyogr Clin Neurophysiol; 2004 Mar; 44(2):67-73. PubMed ID: 15061399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression and bilateralisation of motor signs in Parkinson's disease.
    Cosentino Luis Torres C
    Parkinsonism Relat Disord; 2005 Aug; 11(5):335. PubMed ID: 15886044
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the problem of persistent extrapyramidal hyperkinesia following prolonged use of neuroleptics].
    Degkwitz R; Binsack KF; Herkert H; Luxenburger O; Wenzel W
    Nervenarzt; 1967 Apr; 38(4):170-4. PubMed ID: 4382352
    [No Abstract]   [Full Text] [Related]  

  • 7. Toxins, genetics, and Parkinson's disease: the role of N-acetyltransferase 2.
    Bandmann O; Vaughan J; Holmans PA; Marsden CD; Wood NW
    Adv Neurol; 1999; 80():199-204. PubMed ID: 10410722
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of modern psychotropic drugs by the non-psychiatrist].
    Fleischhauer J
    Internist (Berl); 1972 May; 13(5):179-86. PubMed ID: 4403070
    [No Abstract]   [Full Text] [Related]  

  • 9. Parkinson's disease: a clinical review.
    Lieberman AN
    Am J Med Sci; 1974 Feb; 267(2):66-80. PubMed ID: 4821328
    [No Abstract]   [Full Text] [Related]  

  • 10. Tremor in Parkinson's disease: 24-hr monitoring with calibrated accelerometry.
    Thielgen T; Foerster F; Fuchs G; Hornig A; Fahrenberg J
    Electromyogr Clin Neurophysiol; 2004; 44(3):137-46. PubMed ID: 15125053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Don't let the patient with Parkinson's disease fall!].
    Bloem BR; Grimbergen YA; Roos RA
    Ned Tijdschr Geneeskd; 1998 Dec; 142(52):2825-7. PubMed ID: 10065254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of Parkinson syndrome secondary to combined amineptine and bromazepam abuse].
    Lapaz AG; Pozo P; Romero H; Barcia D
    Encephale; 1998; 24(5):486-8. PubMed ID: 9850824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress and limitation of psychopharmacological therapy].
    Hoff H; Hofmann G
    Psychiatr Neurol Med Psychol (Leipz); 1967 Dec; 19(12):441-8. PubMed ID: 6082949
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of effectiveness of the micrographia's therapy in Parkinson's disease patients].
    Jarzebska E
    Pol Merkur Lekarski; 2006 Jun; 20(120):688-90. PubMed ID: 17007269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Freezing of gait after bilateral subthalamic nucleus stimulation for Parkinson's disease.
    Davis JT; Lyons KE; Pahwa R
    Clin Neurol Neurosurg; 2006 Jul; 108(5):461-4. PubMed ID: 16139421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Symptoms of the extrapyramidal syndrome during maintenence therapy with neuroleptic drugs].
    Sujecka-Szymkiewicz H
    Psychiatr Pol; 1967; 1(1):79-84. PubMed ID: 4876412
    [No Abstract]   [Full Text] [Related]  

  • 17. Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease.
    Devos D; Labyt E; Derambure P; Bourriez JL; Cassim F; Reyns N; Blond S; Guieu JD; Destée A; Defebvre L
    Brain; 2004 Feb; 127(Pt 2):408-19. PubMed ID: 14691060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of motor symptoms upon the quality of life of patients with Parkinson's disease.
    Gómez-Esteban JC; Zarranz JJ; Lezcano E; Tijero B; Luna A; Velasco F; Rouco I; Garamendi I
    Eur Neurol; 2007; 57(3):161-5. PubMed ID: 17213723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical and occupational therapy in Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S156-9. PubMed ID: 12211155
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rhythmical low-frequency muscle stimulation in the therapy of Parkinson's syndrome].
    Jusić A; Dogan S; Fronjek N
    Fortschr Neurol Psychiatr Grenzgeb; 1971 Aug; 39(8):412-20. PubMed ID: 5314978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.